https://www.selleckchem.com/pr....oducts/tulmimetostat
We analyzed 281 patients with significant TBI treated in a single neurosurgical center in Malaysia over a 2-year period. The overall observed 14-day mortality was 9.6%, a 6-month unfavourable outcome of 23.5%, and a 6-month mortality of 13.2%. Overall, both the CRASH and IMPACT models showed good discrimination with AUCs ranging from 0.88 to 0.94 and both models calibrating satisfactorily H-L GoF p0.05 and calibration slopes 1.0 although IMPACT seemed to be slightly more superior compared to the CRASH model. The CRASH and